德国西萨克森州连续三个流感季乙型流感病毒感染的分子与临床特征分析
该研究比较了2015至2018年连续三个流感季德国西萨克森州实验室确诊的乙型流感病例,分析疫苗接种史、临床症状及分子病毒学特征。2015/16季检出75例,2016/17季11例,2017/18季274例;Yamagata谱系占比从7.6%升至100%。成人患者疫苗接种率37.7%,儿童患者4.5%。临床表现相似,但Yamagata株在2017/18季与既往两季系统发育聚类相似。作者建议国家疫苗接种指南采纳世界卫生组织关于使用四价疫苗(含两种乙型流感株Yamagata和Victoria及两种甲型流感株H1N1和H3N2)的建议。
要点
- 2015至2018连续三季乙型流感病例数分别为75、11和274例,Yamagata谱系占比从7.6%升至100%。
- 成人患者流感疫苗接种率为37.7%,儿童患者为4.5%。
- 不同流感季乙型流感病例相对频率有差异,但临床症状保持相似。
核心结论
- 尽管乙型流感病例相对频率不同,临床症状保持相似;Yamagata株在2017/18季与既往两季系统发育聚类相似。
- 世界卫生组织关于使用含两种乙型流感株(Yamagata和Victoria)及两种甲型流感株(H1N1和H3N2)的四价疫苗的建议应纳入国家疫苗接种指南。
研究设计与样本
- 对2015至2018年连续三个流感季德国西萨克森州实验室确诊的乙型流感病例进行回顾性分析。
- 部分HA基因序列用于谱系鉴定,对有报告疫苗接种的病例和死亡病例进行HA基因完整测序。
- 临床数据从患者病历中提取。
主要发现
- 2015/16季检出75例乙型流感病例,2016/17季11例,2017/18季274例。
- Yamagata谱系频率从7.6%增至100%。
- 2017/18季合并症相对频率未见差异。
- 成人患者疫苗接种率为37.7%,儿童患者为4.5%。
- 不同流感季乙型流感病例相对频率不同,但临床症状保持相似。
关键数值与推荐
- Yamagata谱系占比从7.6%升至100%。
- 成人患者疫苗接种率37.7%,儿童患者4.5%。
临床怎么用
- 应实施国家疫苗接种指南采纳世界卫生组织关于使用四价疫苗(含两种乙型流感株Yamagata和Victoria及两种甲型流感株H1N1和H3N2)的建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of annual influenza epidemics and prevailing strains varies worldwide and regional. The majority of vaccines used contained two influenza A strains and only one influenza B strain (trivalent vaccine). AIM: The aim of the study was to compare laboratory confirmed influenza B cases during three consecutive years with respect to vaccination history, clinical symptoms and molecular virology. METHODS: Partial HA gene sequences were analyzed for lineage determination and complete HA sequence in cases with reported vaccination and in fatal cases. Clinical data were retrieved from patient charts. FINDINGS: During the 2015/16 season, 75 influenza B cases were retrieved; 11 in 2016/17, and 274 in 2017/18. The frequency of Yamagata-lineage strains increased from 7.6% to 100%. No difference was detected in the relative frequency of co-morbidities in season 2017/18. 37.7% of the adult patients and 4.5% of pediatric patients were vaccinated against influenza. INTERPRETATION: Phylogenetically, Yamagata strains clustered similarly in 2017/2018 when compared to the previous two influenza seasons. While the relative frequency of influenza B cases differed, the clinical symptoms remained similar. CONCLUSION: World Health Organization recommendations for the use of tetravalent vaccines that contain two influenza B strains (Yamagata and Victoria) in addition to the two influenza A strains (H1N1 and H3N2) should be implemented in national vaccination guidelines. FUNDING: This research was partially supported by the Association of Sponsors and Friends of Leipzig University.
引用
- Hönemann M, Martin D, Pietsch C, et al. Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features. Vaccine. 2019. PMID: 31521415. doi:10.1016/j.vaccine.2019.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。